OncoZenge AB (publ) (ONCOZ.ST)

SEK 3.97

(4.34%)

Gross Profit Summary of OncoZenge AB (publ)

  • OncoZenge AB (publ)'s latest annual gross profit in 2023 was 3000.00 SEK , down 0.0% from previous year.
  • OncoZenge AB (publ)'s latest quarterly gross profit in 2024 Q2 was 1000.00 SEK , down 0.0% from previous quarter.
  • OncoZenge AB (publ) reported a annual gross profit of - SEK in annual gross profit 2022, down 0.0% from previous year.
  • OncoZenge AB (publ) reported a annual gross profit of - SEK in annual gross profit 2021, down 0.0% from previous year.
  • OncoZenge AB (publ) reported a quarterly gross profit of 1000.00 SEK for 2024 Q2, down 0.0% from previous quarter.
  • OncoZenge AB (publ) reported a quarterly gross profit of - SEK for 2023 Q1, down 0.0% from previous quarter.

Annual Gross Profit Chart of OncoZenge AB (publ) (2023 - 2020)

Historical Annual Gross Profit of OncoZenge AB (publ) (2023 - 2020)

Year Gross Profit Gross Profit Growth
2023 3000.00 SEK 0.0%
2022 - SEK 0.0%
2021 - SEK 0.0%
2020 - SEK 0.0%

Peer Gross Profit Comparison of OncoZenge AB (publ)

Name Gross Profit Gross Profit Difference
Alligator Bioscience AB (publ) -160.68 Million SEK 100.002%
Ziccum AB (publ) -23.28 Million SEK 100.013%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 346.31 Million SEK 99.999%
Sprint Bioscience AB (publ) 41.78 Million SEK 99.993%
Mendus AB (publ) 28.48 Million SEK 99.989%
Genovis AB (publ.) 54 Million SEK 99.994%
Intervacc AB (publ) -13.79 Million SEK 100.022%
QuiaPEG Pharmaceuticals Holding AB (publ) 2.17 Million SEK 99.862%
Active Biotech AB (publ) -1.67 Million SEK 100.179%
Magle Chemoswed Holding AB (publ) 9.96 Million SEK 99.97%
Bio-Works Technologies AB (publ) 26.82 Million SEK 99.989%
Aptahem AB (publ) 2.63 Million SEK 99.886%
Vicore Pharma Holding AB (publ) -3.42 Million SEK 100.088%
Kancera AB (publ) -1.96 Million SEK 100.153%
Infant Bacterial Therapeutics AB (publ) 77 Thousand SEK 96.104%
Fluicell AB (publ) 1.73 Million SEK 99.827%
Saniona AB (publ) 11.78 Million SEK 99.975%
Lipigon Pharmaceuticals AB (publ) -5.11 Million SEK 100.059%
Biovica International AB (publ) 6.87 Million SEK 99.956%
Spago Nanomedical AB (publ) -23.28 Million SEK 100.013%
AcouSort AB (publ) 8.38 Million SEK 99.964%
Xintela AB (publ) 78 Thousand SEK 96.154%
Abliva AB (publ) -35.66 Million SEK 100.008%
Egetis Therapeutics AB (publ) -146.9 Million SEK 100.002%
Karolinska Development AB (publ) 2.8 Million SEK 99.893%
Amniotics AB (publ) -1.93 Million SEK 100.155%
2cureX AB (publ) -37.48 Million SEK 100.008%
CombiGene AB (publ) -21.29 Million SEK 100.014%
Asarina Pharma AB (publ) -423 Thousand SEK 100.709%
Calliditas Therapeutics AB (publ) 1.12 Billion SEK 100.0%
Camurus AB (publ) 1.58 Billion SEK 100.0%
Corline Biomedical AB 28.38 Million SEK 99.989%
IRLAB Therapeutics AB (publ) -122.73 Million SEK 100.002%
Isofol Medical AB (publ) -34.41 Million SEK 100.009%
I-Tech AB 27.56 Million SEK 99.989%
Hansa Biopharma AB (publ) 70.95 Million SEK 99.996%
Cyxone AB (publ) 2.61 Million SEK 99.885%
ExpreS2ion Biotech Holding AB (publ) 3.4 Million SEK 99.912%
Biosergen AB -456 Thousand SEK 100.658%
Cantargia AB (publ) -3.45 Million SEK 100.087%
NextCell Pharma AB -43.74 Million SEK 100.007%
Xspray Pharma AB (publ) -9.19 Million SEK 100.033%
Elicera Therapeutics AB (publ) 11.21 Million SEK 99.973%
Nanologica AB (publ) -76 Thousand SEK 103.947%
SynAct Pharma AB -778 Thousand SEK 100.386%
Annexin Pharmaceuticals AB (publ) -193 Thousand SEK 101.554%
Stayble Therapeutics AB (publ) - SEK -Infinity%
LIDDS AB (publ) -12.92 Million SEK 100.023%
Lipum AB (publ) 53 Thousand SEK 94.34%
BioInvent International AB (publ) 71.46 Million SEK 99.996%
Alzinova AB (publ) 19.87 Million SEK 99.985%
Oncopeptides AB (publ) 36.29 Million SEK 99.992%
Pila Pharma AB (publ) 1.46 Million SEK 99.795%
Guard Therapeutics International AB (publ) -15 Thousand SEK 120.0%
Scandinavian ChemoTech AB (publ) 1.65 Million SEK 99.819%
Simris Alg AB (publ) 2 Million SEK 99.851%
Diamyd Medical AB (publ) -3.58 Million SEK 100.084%
Xbrane Biopharma AB (publ) 35.38 Million SEK 99.992%
Ascelia Pharma AB (publ) -1.04 Million SEK 100.286%
Diagonal Bio AB (publ) 3.13 Million SEK 99.904%